Effects of Iron Supplementation on Skeletal Muscle Properties in Females With Suboptimal Iron Storage
Condition(s) studied
Investigational drug(s) / intervention(s)
Oral iron supplement: Encapsulated ferrous sulphate (150mg elemental iron)
Placebo: Encapsulated polysaccharide (maltodextrin)
Study summary
The goal of this clinical trial is to learn whether oral iron supplementation will increase skeletal muscle iron storage and its effects on exercise capacity in females with suboptimal iron status. The study will include healthy females, ages 18-40, who either have suboptimal or optimal iron stores.
The main questions it aims to answer are:
* Does iron supplementation increase skeletal muscle iron storage and alter the expression of iron-related and mitochondrial proteins?
* Does iron supplementation improve single-leg exercise performance?
* Is serum ferritin correlated with the abundance of iron-related proteins in skeletal muscle?
Researchers will compare outcomes from females with suboptimal iron status who receive oral iron supplementation to those who receive a placebo to see if supplementation improves muscle iron storage, protein expression, and exercise performance. Additionally, a non-intervention control group with optimal iron status will be included to assess baseline differences.
Participants will:
\- Be randomly assigned to receive 150 mg elemental iron or placebo (maltodextrin) every other day for 12 weeks
Complete pre- and post-supplementation testing, including:
* Blood draws to assess iron status
* Skeletal muscle biopsies to analyze protein content
* Whole-body and single-leg exercise tests to assess performance
* Controls will undergo baseline-only testing to compare physiological and biochemical markers
Eligibility
Primary outcome measure(s)
- Muscle Ferritin — At baseline (week 0) and completion of supplementation (week 12)
Muscle collection: The muscle biopsy involves the removal of a small piece of muscle tissue from the vastus lateralis using a sterile hollow needle. The area over the incision site will be carefully cleaned, and a small amount of local anesthetic will be injected into and under the skin. A small, 4 - 5 mm incision will be made in the skin to create an opening for the biopsy needle. The biopsy needle will then be inserted through the incision into the muscle, and a small piece of muscle (\~50 mg) will be removed, and the needle taken out. A medical doctor will perform this procedure. Protein analysis: Western blotting will be used to analyze the abundance of ferritin within small sections of the muscle sample.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Calgary | Calgary | Alberta |
More University of Calgary trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07084298 on ClinicalTrials.gov ↗ ← All trials in Canada